DSGN Latest Press Releases

-- November 26, 2025 --

Design Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- November 5, 2025 --

Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results Globe Newswire 4:01 PM

-- September 10, 2025 --

Design Therapeutics Appoints Justin Gover to Board of Directors Globe Newswire 4:01 PM

-- August 30, 2025 --

? ?????, ??? ? ???? ?? ??? ??? ???? ?? Surbhi Jain 3:44 PM

-- August 7, 2025 --

Design Therapeutics Highlights Progress Across Lead GeneTAC Programs and Reports Second Quarter 2025 Financial Results Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software